573 filings
Page 3 of 29
6-K
e1hf0e6pzmoa
26 Jul 22
Material Change Report
3:49pm
6-K
3dpl5a24xmj xi0u
19 Jul 22
Current report (foreign)
4:52pm
6-K
ik6fsl3 p6s
18 Jul 22
Aeterna Zentaris Announces Effective Date of Share Consolidation
5:29pm
6-K
3eru9qcs0q kl
15 Jul 22
Current report (foreign)
4:15pm
6-K
occ0h7qfv
6 Jul 22
Aeterna Zentaris Announces Further Adjournment of Shareholder Meeting
4:05pm
6-K
v0arqopcjhhv9
21 Jun 22
Aeterna Zentaris Announces Results of Annual Meeting of Shareholders
4:12pm
6-K
ioe4rrizj78jv
21 Jun 22
Report of Voting Results
4:04pm
6-K
gcmj7qwsoynp5h
31 May 22
Annual General and Special Meeting of Shareholders
6:12am
6-K
dezynwtidkk1y418vbt
17 May 22
Current report (foreign)
3:04pm
6-K
xs5xkrc7pnxrbfee
16 May 22
Aeterna Zentaris Announces Virtual 2022 Meeting of Shareholders and Urges Shareholders to Vote in Favor of the Proposed Share Consolidation
2:14pm
6-K
tf7o6u7z3w022p0j1rn
11 May 22
Aeterna Zentaris Reports First Quarter 2022 Financial Results and Provides Business Outlook
7:48pm
6-K
tiht2yn crpq
10 May 22
Current report (foreign)
7:18pm
6-K
q2soyjgx bu
19 Apr 22
Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults
8:45pm
6-K/A
by26rorzhk
31 Mar 22
Consolidated Financial Statements
4:05pm
6-K
682a5b5yk h6
29 Mar 22
Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook
8:10am
6-K
r8yuzx0o
28 Mar 22
Consolidated Financial Statements
9:35pm
6-K
wxzqc0u5zg 91iok
10 Mar 22
Current report (foreign)
6:21pm
6-K
jkifa
2 Mar 22
Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism
8:15am
6-K
2lhvyuhhw7j 8h
26 Jan 22
Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
4:29pm
6-K
307o9
26 Jan 22
Aeterna Zentaris Provides Business Outlook and Outlines Pipeline Priorities
4:24pm